Bacteriostatic Water · Research brief

Melanotan-2 Vial Size — Dosing & Storage Guide

Real Peptides Research TeamEditorial

Updated March 26, 202612 min read

60 WORDS

Short answer

Key takeaways

The standard melanotan-2 vial size is 10mg lyophilised powder in a sterile, vacuum-sealed glass vial, designed for reconstitution with bacteriostatic water at concentrations between 1mg/mL and 2mg/mL.
Reconstitution volume determines dosing accuracy—draw volumes below 0.3mL introduce significant pipetting error, so most researchers reconstitute at concentrations that keep draw volumes between 0.3mL and 1mL per dose.
Once reconstituted, melanotan-2 vials must be refrigerated at 2–8°C and used within 28 days before oxidative degradation reduces potency below 90% of original concentration.
Unreconstituted lyophilised melanotan-2 remains stable for 24+ months when stored at −20°C, but only 6–12 months at standard refrigeration temperatures (2–8°C).
Each needle puncture through the rubber stopper is a contamination risk point—larger vial sizes requiring 20+ draws over 28 days carry higher sterility breach risk than smaller vials reconstituted fresh every 10–14 days.
Vacuum integrity during shipping is a critical quality checkpoint—peptide vials exposed to oxygen during transport degrade rapidly, so visual inspection for intact vacuum seal before reconstitution is non-negotiable.

The melanotan-2 vial size most researchers receive—10mg of lyophilised powder in a sterile glass container—looks standardized, but the way you reconstitute and store that peptide determines whether your research protocol succeeds or fails. A single temperature excursion above 8°C after mixing can denature the melanocortin receptor agonist structure entirely, turning what should be a stable compound into an ineffective solution. The difference between functional peptide and wasted material comes down to three factors most purchasing guides never address: reconstitution volume, multi-dose contamination risk, and cold chain integrity from synthesis to storage.

We've worked with research institutions navigating peptide procurement for years. The gap between doing it right and compromising an entire study comes down to understanding that vial size isn't just a packaging decision—it's a dosing variable that affects concentration, sterility maintenance across multiple draws, and the degradation timeline once bacteriostatic water is added.

What is the standard melanotan-2 vial size used in research settings?

The standard melanotan-2 vial size is 10mg of lyophilised powder supplied in a sterile, vacuum-sealed glass vial designed for single or multi-dose reconstitution with bacteriostatic water. Once reconstituted at typical research concentrations (1mg/mL to 2mg/mL), a 10mg vial yields 5–10 administrations depending on dosing protocol, with refrigerated stability maintained for approximately 28 days at 2–8°C.

Most researchers assume all 10mg melanotan-2 vials are functionally identical, but that assumption ignores the three variables that determine usability: fill variance (±5–10% from stated dose due to lyophilisation loss), sterility assurance (USP <797> compliance during compounding), and vacuum integrity during shipping. The peptide you receive isn't necessarily the peptide concentration printed on the label—batch testing with HPLC (high-performance liquid chromatography) is the only verification method that confirms actual peptide content. The rest of this piece covers exactly how vial size affects dosing calculations, what reconstitution ratios preserve peptide stability longest, and what preparation mistakes compromise the entire batch before the first administration.

Understanding Melanotan-2 Vial Size Standards in Research Contexts

Melanotan-2 vial size in research-grade supply follows a relatively narrow range: 10mg lyophilised powder is the industry standard because it balances manufacturing efficiency with practical research dosing needs. The peptide exists as a white to off-white powder inside a sterile glass vial sealed under vacuum—oxygen exposure degrades melanocortin receptor agonists rapidly, so vacuum integrity during transport is a critical quality checkpoint. The 10mg format allows researchers to reconstitute at concentrations between 0.5mg/mL and 2mg/mL depending on protocol requirements, creating between 5mL and 20mL of working solution from a single vial.

Why 10mg became the standard: early melanocortin receptor research used doses ranging from 0.25mg to 2mg per administration in animal models, meaning a 10mg vial provided 5–40 administrations depending on the study design. Larger vials (20mg or 50mg bulk powder) introduce contamination risk across dozens of needle punctures through the rubber stopper—each puncture is a sterility breach point. Smaller vials (2mg or 5mg) increase per-dose cost and require more frequent reconstitution, which adds procedural variability. The 10mg format sits at the practical midpoint: enough material for a full study cohort without requiring bulk powder handling protocols.

Reconstitution math matters more than vial size alone. If you add 5mL of bacteriostatic water to a 10mg vial, you've created a 2mg/mL solution—meaning each 0.5mL (500 microliter) draw contains 1mg of peptide. If you add 10mL to the same vial, you've created a 1mg/mL solution where each 1mL draw contains 1mg. The concentration you choose determines needle draw volume, which affects measurement precision: drawing 0.1mL with a 1mL insulin syringe is significantly more accurate than drawing 0.05mL, where meniscus reading error can produce ±20% dose variance. Most experienced researchers reconstitute at 1mg/mL to 1.5mg/mL specifically to keep draw volumes above 0.3mL, where syringe graduation marks provide reliable measurement.

Vial size also determines degradation exposure. Once reconstituted, melanotan-2 in aqueous solution begins slow oxidative degradation even under refrigeration—the half-life of reconstituted melanocortin peptides at 4°C is approximately 28–35 days before potency drops below 90% of original concentration. A 10mg vial reconstituted to 10mL and stored for 28 days experiences the same time-based degradation as a 10mg vial reconstituted to 5mL—but the 10mL version has twice as much unused peptide volume sitting in the vial degrading between uses. If your protocol only requires 5mg total across a study, reconstituting the full 10mg vial means 5mg will degrade unused. Smaller initial vial sizes (5mg) would reduce waste, but most suppliers don't offer them due to manufacturing batch size economics.

At Real Peptides, every peptide batch undergoes small-batch synthesis with exact amino-acid sequencing to guarantee purity and consistency. When researchers source Melanotan 2 MT2 10mg, they're receiving peptide with verified HPLC purity reports and vacuum-sealed sterility—not relying on supplier declarations without third-party verification. That level of precision matters when vial size and reconstitution protocols depend on accurate starting peptide mass.

Reconstitution Protocols and How Vial Size Affects Dosing Accuracy

The melanotan-2 vial size you start with determines the reconstitution strategy you can use—and reconstitution strategy determines dosing precision across the entire study timeline. Lyophilised peptides require reconstitution with bacteriostatic water (0.9% benzyl alcohol in sterile water for injection) rather than plain sterile water because multi-dose vials need antimicrobial protection between draws. Each time you puncture the rubber stopper with a needle, you introduce contamination risk—bacteriostatic water suppresses bacterial growth for up to 28 days, but it doesn't eliminate the risk entirely.

Reconstitution volume directly controls peptide concentration, which controls measurement error. Standard research protocols reconstitute 10mg melanotan-2 vials with 5mL to 10mL bacteriostatic water, producing concentrations of 2mg/mL to 1mg/mL respectively. The lower the concentration (more water added), the larger the volume you'll draw per dose—which improves measurement accuracy but increases the number of needle punctures required to use the full vial. The higher the concentration (less water added), the smaller the draw volume per dose—which reduces puncture frequency but increases pipetting error on small-volume draws.

Here's the calculation sequence every researcher should run before adding water to the vial: (1) Determine your target dose per administration in milligrams. (2) Decide how many administrations the vial needs to provide. (3) Choose a reconstitution volume that results in a draw volume between 0.3mL and 1mL per dose—this is the range where standard 1mL insulin syringes provide reliable accuracy. Example: if your protocol calls for 0.5mg per dose and you want 20 doses from a 10mg vial, reconstitute with 10mL bacteriostatic water to create a 1mg/mL solution—each 0.5mL draw delivers exactly 0.5mg.

The reconstitution process itself introduces variability if not executed with sterile technique. Never inject air into the vial while adding bacteriostatic water—this creates positive pressure inside the sealed vial, which forces liquid back through the needle during withdrawal and increases contamination risk on every subsequent draw. Instead, draw your desired volume of bacteriostatic water into the syringe, insert the needle through the vial's rubber stopper at a 45-degree angle, and allow the vacuum inside the vial to pull the water in slowly. The lyophilised peptide will dissolve without agitation—never shake a reconstituted peptide vial, as mechanical stress can cleave peptide bonds and reduce bioactivity.

Once reconstituted, the 10mg melanotan-2 vial must be stored at 2–8°C (refrigeration) and used within 28 days. This is not a suggestion—it's a stability threshold. Melanocortin receptor agonists in aqueous solution undergo oxidative degradation and hydrolysis at room temperature, with potency loss accelerating above 15°C. A vial left on a lab bench for four hours during a protocol day can lose 10–15% potency before it's returned to the refrigerator. The smaller your vial size relative to total study needs, the more frequently you'll reconstitute fresh vials—which increases cost but maximizes peptide potency across administrations.

In our experience working with research teams, the reconstitution step is where most procedural errors occur—not during administration. The mistake we see most often: researchers reconstitute the entire 10mg vial at the start of a multi-week study, then draw from it daily for 35–40 days, assuming bacteriostatic water alone preserves potency indefinitely. It doesn't. The peptide degrades, the doses administered in week 5 contain significantly less active compound than the doses in week 1, and study results show unexplained variability that's actually due to declining peptide concentration over time.

Melanotan-2 Vial Size: Storage & Stability Comparison

Understanding how melanotan-2 vial size intersects with storage requirements prevents the most common research failures: peptide degradation due to temperature excursions, contamination from improper multi-dose handling, and potency loss from extended reconstituted storage. The table below compares key variables across typical vial formats to help researchers match vial size to study design.

The critical takeaway: melanotan-2 vial size alone doesn't determine stability—reconstitution volume, storage temperature, and time since mixing are the controlling variables. A 10mg vial reconstituted and used within 14 days will outperform a 5mg vial reconstituted and stored for 35 days, even though the smaller vial sounds more conservative. The peptide doesn't know what size vial it came in; it only responds to temperature, time in solution, and sterility maintenance.

Temperature excursions are the silent killer of peptide research. Every time a reconstituted vial is removed from refrigeration for a draw and returned, it undergoes a warming and cooling cycle. If that cycle is brief (vial out for 2–3 minutes, then immediately returned to 4°C), degradation is minimal. If the vial sits at room temperature for 20 minutes while you prepare syringes, calculate doses, and clean the workspace, you've introduced measurable potency loss. Multiply that across 20 administrations over four weeks, and you're administering significantly degraded peptide by the final doses. Smaller vial sizes reconstituted fresh every 10–14 days eliminate this cumulative degradation—but only if you're disciplined about actually reconstituting fresh vials on schedule.

What If: Melanotan-2 Vial Size Scenarios

What If My Reconstituted Melanotan-2 Vial Sat at Room Temperature Overnight?

Discard it. Melanocortin receptor agonists in aqueous solution degrade rapidly above 15°C—eight hours at room temperature (20–25°C) can reduce potency by 30–50%, and there's no way to verify remaining activity without HPLC testing. The cost of replacing one vial is far lower than the cost of continuing a study with degraded peptide producing unreliable results. Unreconstituted lyophilised powder is more forgiving—if a sealed vial was shipped without refrigeration but arrived within 48 hours, it's likely still viable, though you should request a replacement or potency verification from the supplier.

What If I Need to Store a Reconstituted Vial for Longer Than 28 Days?

You can extend storage slightly by reconstituting at higher concentrations (2mg/mL instead of 1mg/mL), which reduces the water volume and slows hydrolysis—but you're still working against oxidative degradation that bacteriostatic water doesn't prevent. Realistically, potency drops measurably after 28 days even under ideal refrigeration. If your study timeline extends beyond four weeks, reconstitute only the amount you'll use in that window and store the remaining powder unreconstituted at −20°C. A 10mg vial can be split across two reconstitution events if you work in a sterile environment, though this introduces additional contamination risk.

What If My Protocol Requires Doses Smaller Than 0.1mg—Should I Choose a Larger Vial Size?

No—choose a lower reconstitution concentration instead. If you need 0.1mg per dose, reconstitute a 10mg vial with 20mL bacteriostatic water to create a 0.5mg/mL solution, then draw 0.2mL (200 microliters) per dose. This keeps your draw volume in the measurable range for standard insulin syringes. Larger vial sizes (20mg or 50mg) don't solve small-dose measurement problems—they just create more unused peptide degrading in the vial between administrations.

What If I Accidentally Punctured the Rubber Stopper Multiple Times in One Session?

The immediate contamination risk is low if you used sterile technique, but you've compromised the stopper's integrity. Each puncture creates a potential pathway for airborne contaminants to enter the vial during storage. If the vial will be used within 7–10 days, the risk is manageable. If you're planning to store it for the full 28-day window, consider reconstituting a fresh vial to eliminate the variable—especially for critical study phases where result reliability matters most.

The Practical Truth About Melanotan-2 Vial Size

Here's the honest answer: melanotan-2 vial size matters far less than what you do with the vial after it arrives. The 10mg standard exists because it works for most research protocols—not because it's optimized for every possible use case. The real determinant of whether your peptide performs as expected is reconstitution discipline: accurate bacteriostatic water volume, sterile needle technique, consistent refrigeration at 2–8°C, and adherence to the 28-day post-reconstitution stability window. Researchers who obsess over whether to order 5mg or 10mg vials but then store reconstituted peptide for 40 days at inconsistent temperatures are optimizing the wrong variable.

The vial size you should choose depends entirely on your study timeline and dosing frequency. If you're running a four-week protocol with daily administrations at 0.5mg per dose, a single 10mg vial reconstituted at 1mg/mL gives you 20 doses—exactly what you need with minimal waste. If you're running a pilot study with five total administrations, a 5mg vial would reduce waste, but most suppliers don't stock them because the per-milligram manufacturing cost is higher. In that case, order the 10mg vial, reconstitute half the powder with 5mL bacteriostatic water, and keep the other half as unreconstituted powder stored at −20°C for future use—but only if you have the equipment and sterile environment to split the vial safely.

The mistake most researchers make isn't choosing the wrong vial size—it's failing to track reconstitution dates and continuing to use peptide beyond the stability window because

References

Peer-reviewed sources on Melanotan-2 indexed in PubMed, listed for research context. Real Peptides supplies Melanotan-2 for laboratory research use only.

Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN case reports, 2020. PMID 31953620. doi:10.1007/s13730-020-00447-z
Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition. International journal of molecular sciences, 2020. PMID 31968661. doi:10.3390/ijms21020681
The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents. The Journal of pharmacology and experimental therapeutics, 2007. PMID 17567964. doi:10.1124/jpet.107.123091
Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2003. PMID 12704398. doi:10.1038/sj.ijo.0802280
MTII administered peripherally reduces fat without invoking apoptosis in rats. Physiology & behavior, 2003. PMID 12834806. doi:10.1016/s0031-9384(03)00118-5
Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain research, 2003. PMID 12834882. doi:10.1016/s0006-8993(03)02683-0

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

The standard melanotan-2 vial size is 10mg of lyophilised powder in a sterile glass vial. This format is designed for reconstitution with bacteriostatic water at concentrations typically ranging from 1mg/mL to 2mg/mL, providing between 5 and 20 doses depending on the research protocol. Some suppliers offer 5mg vials for smaller studies, but the 10mg format is the industry standard due to manufacturing efficiency and practical multi-dose use.

Once reconstituted with bacteriostatic water, a 10mg melanotan-2 vial remains stable for approximately 28 days when stored at 2–8°C under refrigeration. After this window, oxidative degradation and hydrolysis reduce peptide potency below 90% of the original concentration. Unreconstituted lyophilised powder stored at −20°C maintains stability for 24+ months, but only 6–12 months at standard refrigeration temperatures.

Most researchers reconstitute 10mg melanotan-2 vials with 5mL to 10mL of bacteriostatic water, producing concentrations of 2mg/mL or 1mg/mL respectively. The volume you choose should result in draw volumes between 0.3mL and 1mL per dose to minimize pipetting error—smaller draw volumes below 0.3mL introduce significant measurement variability with standard insulin syringes. Calculate backward from your target dose per administration to determine optimal reconstitution volume.

Unreconstituted lyophilised melanotan-2 vials should be stored at −20°C for maximum shelf life, though they can tolerate short-term storage at 2–8°C for up to 12 months. Extended room temperature storage (above 15°C) accelerates degradation even in lyophilised form—while the peptide won’t degrade as rapidly as reconstituted solution, potency loss over weeks or months at ambient temperature is measurable. Always refrigerate or freeze unreconstituted vials upon receipt.

Vial size itself doesn’t directly affect accuracy—reconstitution concentration does. A 10mg vial reconstituted with 10mL bacteriostatic water yields 1mg/mL, requiring a 0.5mL draw for a 0.5mg dose. The same vial reconstituted with 5mL yields 2mg/mL, requiring only a 0.25mL draw for the same dose. Smaller draw volumes increase measurement error, so researchers typically choose reconstitution volumes that keep individual dose draws above 0.3mL to maintain precision with standard syringes.

A 5mg vial reduces waste for studies requiring fewer than 10 total administrations, but most suppliers don’t stock them due to higher per-milligram manufacturing costs. If your protocol needs only 5mg total, ordering a 10mg vial and reconstituting half while storing the other half as lyophilised powder at −20°C is an option—but only if you have sterile handling capability to split the vial safely. For most researchers, the 10mg standard is the practical choice even if some peptide goes unused.

Potency declines measurably after 28 days even under proper refrigeration due to oxidative degradation and peptide bond hydrolysis. A vial stored for 35–40 days may look visually identical to fresh peptide but contain 30–50% less bioactive compound. This introduces uncontrolled variability into research results—early administrations deliver full-potency peptide while later administrations deliver degraded material. Always reconstitute fresh vials rather than extending use beyond the stability window.

While rubber stoppers are designed for multi-dose use, each puncture is a potential contamination entry point. A 10mg vial providing 20 doses requires 20 punctures over the storage period—moderate contamination risk if sterile technique is maintained. Excessive punctures in a single session or using large-gauge needles can compromise stopper integrity, creating pathways for airborne contaminants. If you puncture the stopper more than 25–30 times or notice visible degradation, consider reconstituting a fresh vial.

Vial size doesn’t meaningfully affect temperature tolerance—peptide degradation during shipping depends on whether the lyophilised powder maintains vacuum seal and stays below 25°C. Unreconstituted melanotan-2 can tolerate brief ambient temperature exposure (24–48 hours) during shipping if properly sealed, but extended heat exposure above 30°C accelerates degradation. Always verify that suppliers use cold chain shipping with ice packs or temperature-controlled packaging, and inspect vacuum seal integrity upon receipt regardless of vial size.

Technically yes, but only if you have a sterile environment and proper technique to prevent contamination when accessing the lyophilised powder. Most researchers lack the equipment to split vials safely, so the standard approach is to reconstitute the full 10mg vial and use it within the 28-day stability window. If you need to extend peptide use across a longer timeline, order multiple smaller vials and reconstitute them sequentially rather than attempting to split a single vial mid-study.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA